VEGFA and retinopathy of prematurity: Importantly, while our study documented no cases requiring treatment during a five-year period, Blazon et al. [24] reported treatment-requiring ROP in 4.8% of screened infants, with 11.8% of cases progressing to stage 3 disease and necessitating laser photocoagulation or intravitreal anti-VEGF therapy.